Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Caribou Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +17 vs. Q1 2022
- Shares held
- 37.3M
- +3.24M (+9.5%) vs. Q1 2022
- Total value
- $203.0M
- −$110.1M (−35.2%) vs. Q1 2022
- New holders
- 31
- 34 more added
- Sold out
- 14
- 34 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2.57M | 3.98% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 509,568 | $2.77M | 0.00% | −6,190−1.2% | Reduced |
| Memorial Sloan Kettering Cancer Center | 609,196 | $3.31M | 10.93% | −65,000−9.6% | Reduced |
| Morgan Stanley | 643,183 | $3.49M | 0.00% | +440,295+217.0% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 652,542 | $3.54M | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 674,773 | $3.66M | 0.00% | +26,016+4.0% | Added |
| Tekla Capital Management LLC | 699,377 | $3.80M | 0.15% | 00.0% | Unchanged |
| State Street Corp | 797,600 | $4.33M | 0.00% | +54,578+7.3% | Added |
| FIL Ltd | 860,666 | $4.67M | 0.01% | −10.0% | Reduced |
| Alkeon Capital Management LLC | 873,549 | $4.74M | 0.03% | −350,000−28.6% | Reduced |
| Assenagon Asset Management S.A. | 1,109,929 | $6.03M | 0.03% | +1,109,929 | New |
| FMR LLC | 1,524,335 | $8.28M | 0.00% | −488,698−24.3% | Reduced |
| Rokos Capital Management LLP | 1,907,509 | $10.6M | 0.84% | +1,058,175+124.6% | Added |
| Vanguard Group Inc | 1,992,363 | $10.8M | 0.00% | −9,191−0.5% | Reduced |
| Farallon Capital Management, L.L.C. | 2,203,895 | $12.0M | 0.07% | −453,157−17.1% | Reduced |
| Pictet Asset Management SA | 2,689,227 | $14.6M | 0.02% | +4,679+0.2% | Added |
| Avidity Partners Management LP | 2,950,000 | $16.0M | 0.37% | +130,933+4.6% | Added |
| BlackRock Inc. | 4,049,786 | $22.0M | 0.00% | +730,604+22.0% | Added |
| PFM Health Sciences, LP | 6,000,000 | $32.6M | 1.27% | +1,629,455+37.3% | Added |
| International Biotechnology Trust PLC | 1,378 | – | – | +1,378 | New |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −470,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −101,600−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −24,456−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −16,400−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −15,652−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,981−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,812−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −8,043−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,063−100.0% | Sold out |
| Herold Advisors, Inc. | 0 | $0 | 0.00% | −1,750−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |